The Dry Powder Inhaler Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Dry Powder Inhaler Market?
The global dry powder inhaler market has seen significant growth recently. The market size was $21.25 billion in 2024, and it is predicted to reach $22.35 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Dry Powder Inhaler Industry?
In 2029, the dry powder inhaler market is projected to reach a size of $27.13 billion, expanding at a compound annual growth rate (CAGR) of 5.0%.
Download Your Free Sample of the 2025 Dry Powder Inhaler Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Dry Powder Inhaler Market?
The key drivers in the dry powder inhaler market are:
• Continued emphasis on sustainability within the industry
• Advancements in manufacturing processes for dry powder inhalers
• Government incentives and economic factors supporting market growth
• Increased research and development efforts in the sector
Global Market Segmentation: Identifying Major Dry Powder Inhaler Industry Segments
The dry powder inhaler market covered in this report is segmented –
1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users
Pre-order the 2025 Dry Powder Inhaler Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Dry Powder Inhaler Market?
The key trends in the dry powder inhaler market are:
• Emphasis on sustainability shapes the future trends of the dry powder inhaler market.
• Global urbanization trends play a crucial role in the market's dynamics.
• Advancements in manufacturing processes significantly influence future trends.
• Government incentives and policies also contribute to the emerging trends of this market.
Who Are the Top Competitors & Leading Players in the Dry Powder Inhaler Market?
Major companies in the dry powder inhaler market are:
• Novartis AG
• AstraZeneca plc.
• GlaxoSmithKline PLC
• 3M Company
• Boehringer Ingelheim GmbH
• Viatris (Mylan N.V)
• Otsuka Pharmaceutical Co. Ltd.
• Sun Pharmaceutical Industries Limited
• Catalent Inc.
• Aptar Group Inc.
• Chiesi Farmaceutici S.p.A.
• Recipharm AB
• Cipla Limited
• Lupin Limited
• Orion Corporation
• OPKO Health
• Zhejiang Hisun Pharmaceutical Co Ltd.
• Beximco Pharmaceuticals Ltd.
• Sava Healthcare Ltd.
• Hovione
• Elpen S.A.
• MannKind Corporation
• Meda Pharmaceuticals
• Presspart Manufacturing Ltd.
• SMB Laboratories SA
• Teva Pharmaceutical Industries Limited
• Pharmaxis Ltd.
• Iconovo AB
• SRS Pharmaceuticals Pvt. Ltd.
Regional Dominance: Which Area Leads the Global Dry Powder Inhaler Market?
North America was the largest region in the dry powder inhaler market in 2024
